No Image

Bulls, Bears: 3 Promising Stocks in Metastatic Cancer

September 5, 2012 OneMedPlace Team 1

In this special series, we explore the state of select public companies operating in a particularly intriguing area of life sciences. This week, we look at metastatic cancer, an area of significant unmet need. These companies, including OncoSec Medical, are having success with their innovative approaches to treating metastatic cancer, and are seeing results in their performance int he public markets.

No Image

Inovio Biomedical (AMEX: INO): A DNA Vaccine Delivery Innovator

October 8, 2009 vanderson 0

Inovio Biomedical (AMEX: INO) is developing a robust pre-clinical and early clinical stage pipeline of innovative DNA-based vaccines and therapeutics that target cancer, influenza, and other infectious diseases (e.g. HIV) based on its SynCon DNA vaccine construct and electroporation DNA delivery technology platforms.